VP, US Market Access
Description
Cornerstone Search Group has been retained by a fast-growing, late-stage, multi-asset, rare disease biotech with a very strong cash position, $1Bn+ market cap, and a strong culture set by an experienced executive team. This position will be the company’s inaugural Vice President (Head) of Market Access, and as such will build the US Market Access organization from scratch (including pricing, contracting, account management, distribution, patient services, etc.) in anticipation of their first launch in the second half of 2024.
DESIRED SKILLS / QUALIFICATIONS / EXPERIENCE / BEHAVIORS:
- Significant experience in US Market Access is required. Seeking experience across a range of market access functions such as payer engagement, government pricing, trade & distribution, billing & coding, list pricing strategies, etc. Patient assistance program experience is a plus.
- Prior US Market Access department leadership experience is a plus but not required.
- Experience with hiring, leading, and developing teams required.
- Rare disease experience is a plus, but not required. Oncology and other TAs will be considered.
- Prescription drug launch experience is required.
- Strong financial modeling skills.
- Ex-US experience (ideally in Europe) is a plus.
- Seeking a proactive, self-motivated, and strategic individual who is transparent, builds trusting relationships, and can communicate in a crisp and compelling manner.
- A desire to work in a fast-paced, hands-on, and entrepreneurial culture.
Location
Our client will consider candidates who can work locally 2-3 days per week in their San Francisco Bay Area office as well as candidates from the US or Canada who would want to work remotely.
Features
- Company well positioned for enduring success: This late-stage biotech is helmed by a proven executive management team, has multiple differentiated clinical-stage assets, an extremely strong cash position, and a high market cap (>$1Bn) reflecting Wall Street’s excitement about this company’s future prospects.
- Opportunity to build the US Market Access organization from scratch for 2H 2024 launch
- Company will consider either Hybrid or Remote work arrangements
- Report to an experienced CCO with both small and large pharma experience
- Unlike at most biotechs, the New Hire and Annual LTI Awards include both Options and RSUs
Market competitive base salary and annual bonus plus very strong new hire and annual stock awards that attractively feature both stock options and RSUs, both of which vest aggressively. RSUs are unusual for pre-commercial stage biotechs.
Responsibilities
- Build a wide-ranging market access department with capabilities across pricing, contracting, strategic account management, patient support services, payer value proposition message development, product distribution, specialty pharmacy network management, and government price reporting.
- Determine US list/WAC prices for the pipeline of products along with related payer contracting strategies and patient co-pay assistance programs.
- Lead contracting discussions with payers to ensure patient access.
- Assess the need for a patient support hub and implement it accordingly.
- Evaluate, select, and partner with third-party vendors for the management of patient assistance programs, government price reporting requirements, patient support hub, etc.
- Partner with Medical Affairs to conduct pre-approval meetings with payer medical directors to communicate unmet need and value dossiers.
- Partner with HEOR to construct economic models and data sets in support of payer value proposition messages.
- Proactively monitor trends and developments in federal and state legislation as well as insurance industry policies across a multitude of payer environments including commercial, Medicare, and Medicaid. Develop strategies to influence government and commercial payers.
- Incorporate market access and payer perspectives into clinical development and lifecycle plans.
Contact
Recently Completed Retained Searches by Cornerstone
- CEO | specialty pharma start-up
- CEO | regenerative medicine start-up
- US CEO | established European small pharma
- President/US Commercial Head | generics pharma
- CMO | late-stage public biotech
- CMO | mid-size pharma
- CSO | mid-size global biotech
- SVP, Head of Global Medical Affairs | mid-size oncology company
- SVP, Head of Global Clinical Development | multi-TA mid-size pharma
- SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech
- Group VP, Global Commercial Head | API Business Unit | Indian pharma
- VP, Data Science RWE | Top 5 Pharma
- VP, Head of Regulatory Affairs | Boston biotech
- VP, US Head of Regulatory Affairs | Top 20 Pharma
- VP, Head of R&D Operations | Boston biotech
- VP, Head of Health Economics & Outcomes Research | Top CNS specialty pharma
- VP, Head of Real-World Evidence | Top 5 pharma
- VP, Head of Global Market Access | Top Oncology Specialty Pharma
- VP, Head of Heme/Onc Clinical Research | Public oncology biotech
- VP, Head of Clinical Development | late-stage anti-infectives UK pharma
- VP, Head of Global Drug Safety & PV | Chinese oncology biotech
- ED, Head of Clinical Operations | British VC-backed biotech
- ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma
- ED, Head of Global Clinical Pharmacology | Public oncology biotech
- Head, Patient Advocacy | European commercial-stage rare disease biotech
- Medical Directors (Director/SD/ED levels) in Translational Medicine / Clinical Development / Medical Affairs / Drug Safety: 75+ retained assignments
- HEOR/RWE/Market Access (AD/Director/SD/ED levels): 100+ retained assignments
Cornerstone's Privacy Policy
Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.